Novartis AG Sponsored ADR - NVS

Novartis AG Sponsored ADR represents ownership in Novartis AG, a global healthcare company focused on researching, developing, manufacturing, and marketing innovative medicines. Through this ADR structure, U.S. investors can gain exposure to Novartis AG shares in U.S. dollars, with each depositary receipt backed by an underlying Novartis share held by a depositary bank. Novartis today concentrates on prescription pharmaceuticals across key therapeutic areas such as oncology, cardiovascular, immunology, neuroscience, and ophthalmology, offering treatments for a wide range of chronic and acute conditions. The company’s portfolio includes both established medicines and newer targeted and specialty therapies, supported by significant investment in clinical research and development. Novartis AG Sponsored ADR plays a notable role in the global healthcare sector by providing access to a diversified range of branded drugs that serve hospitals, clinics, and pharmacies worldwide, while giving international investors a convenient mechanism to participate in the performance of a major Swiss-based pharmaceutical company.